Sotera Health Company (SHC) Q4 2025 Earnings Call Transcript

Sotera Health Company (SHC) Q4 2025 Earnings Call Transcript

Seeking Alpha • 6 hours ago

Sotera Health Delivers 20th Consecutive Year of Revenue Growth and Provides 2026 Outlook

2025 net revenues increased 5.7% to $1.164 billion , compared to 2024, or 5.2% on a constant currency basis 2025 net income increased to $78 million or $0.27 per diluted share, compared to net income of $44 million, or $0.16 per diluted share, in 2024 2025 Adjusted EBITDA (1) increased 8.2% to $594 million, compared to 2024, or 7.8% on a constant currency basis 2025 Adjusted EPS (1) of $0.86, an increase of $0.16 per diluted share, compared to 2024 Full-year 2026 outlook: net revenues growth of 5.0% to 6.5% and Adjusted EBITDA growth of 5.5% to 7.0%, on a constant currency basis CLEVELAND, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Sotera Health Company (“Sotera Health” or the “Company”) (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions, lab testing and advisory services for the healthcare industry, today announced financial results for the fourth-quarter and full-year 2025 and its initial 2026 outlook. Fourth-quarter 2025 net revenues increased 4.6% to $303 million, compared to $290 million in the fourth-quarter 2024.

GlobeNewsWire • 12 hours ago

Sotera Health (SHC) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

While the top- and bottom-line numbers for Sotera Health (SHC) give a sense of how the business performed in the quarter ended December 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Zacks Investment Research • 9 hours ago

Sotera Health Company (SHC) Q4 Earnings and Revenues Beat Estimates

Sotera Health Company (SHC) came out with quarterly earnings of $0.26 per share, beating the Zacks Consensus Estimate of $0.24 per share. This compares to earnings of $0.21 per share a year ago.

Zacks Investment Research • 9 hours ago

Sotera Health Announces Fourth-Quarter and Full-Year 2025 Earnings Release Date

CLEVELAND, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions, lab testing and advisory services for the healthcare industry, today announced its plans to release its financial results for the fourth-quarter and full-year ended December 31, 2025 before the market opens on Tuesday, February 24, 2026. Following the release, management will hold a conference call at 9:00 a.m.

GlobeNewsWire • Feb 17, 2026

Sotera Health Appoints Richard Kyle to the Board of Directors

CLEVELAND, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions, lab testing and advisory services for the healthcare industry, announced today it has appointed Richard G. Kyle as a new independent director to its Board of Directors.

GlobeNewsWire • Feb 5, 2026

Sotera Health to Showcase Continued Revenue Growth and Strategic Value Creation at 44th Annual J.P. Morgan Healthcare Conference

CLEVELAND, Jan. 12, 2026 (GLOBE NEWSWIRE) -- Sotera Health Company (“Sotera Health” or the “Company”) (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions, lab testing and advisory services for the healthcare industry, is presenting today at the 44th Annual J.P. Morgan Healthcare Conference.

GlobeNewsWire • Jan 12, 2026

Sotera Health Company (SHC) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Sotera Health Company (SHC) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Seeking Alpha • Jan 12, 2026

Sotera Health Director Warburg Pincus Sells 9.7 Million Shares for $158.7 Million

9,720,000 shares were sold indirectly for a transaction value of ~$158.7 million on Dec. 3, 2025. The sale represented 22.18% of total indirect holdings, reducing indirect exposure from 43,822,952 to 34,102,952 shares.

The Motley Fool • Jan 8, 2026

Sotera Health to Present at the 44th Annual J.P. Morgan Healthcare Conference

CLEVELAND, Jan. 07, 2026 (GLOBE NEWSWIRE) -- Sotera Health Company (“Sotera Health” or the “Company”) (NASDAQ: SHC), a leading global provider of mission-critical end-to-end sterilization solutions, lab testing and advisory services for the healthcare industry, today announced that management will present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, 2026 at 1:30 p.m.

GlobeNewsWire • Jan 7, 2026